Real-time insights. Smarter decisions. Better trades.
🔍 Search Stocks 14 day Free Trial
CANN GROUP LIMITED (CAN)ASX AI Signals has generated 6 signals for CAN during the last 90 days, indicating strong trading activity and ongoing AI monitoring
Latest CAN Signals | |
| 01/07/2026 | BUY |
| 29/06/2026 | SELL |
| 28/06/2026 | SELL |
CAN Share Price | |
| Current Price | $0.005 |
| 52 Week High | $0.019 |
| 52 Week Low: | $0.002 |
| Trading at (% of 52 Week High) | 26.32% |
Cann Group Limited (ASX: CAN) is an Australian company specializing in the production and distribution of medical cannabis products. The company focuses on cultivating, manufacturing, and supplying pharmaceutical-grade cannabis for the healthcare sector.
The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.
The BUY signal for CANN Group Limited is supported by potential upside due to its low price, but overall confidence remains low due to high volatility, limited liquidity, and sector-specific risks.
Cann Group (ASX:CAN) First Half 2023 Results
Key Financial Results
Net loss: AU$18.8m (loss widened by 128% from 1H 2022). AU$0.053 loss per share (further deteriorated from AU$0.028 loss in 1H 2022). earnings-and-revenue-history
All figures shown in the chart above are for the trailing 12 month This week we saw the Cann Group Limited (ASX:CAN) share price climb by 16%. But that doesn't change the fact that the returns over the last three years have been stomach churning. In that time the share price has melted like a snowball in the desert, down 79%. So it sure is nice to see a bit of an i Cann Group Limited (ASX:CAN) shareholders will doubtless be very grateful to see the share price up 35% in the last month. But that is meagre solace in the face of the shocking decline over three years. Indeed, the share price is down a whopping 84% in the last three years. So we're relieved for lon As every investor would know, not every swing hits the sweet spot. But you have a problem if you face massive losses more than once in a while. So take a moment to sympathize with the long term shareholders of Cann Group Limited (ASX:CAN), who have seen the share price tank a massive 88% over a thre BioHarvest Sciences Inc., Icanic Brands Co Inc. & Cann Group Ltd. Among Top Cannabis Gainers For The Week. TerrAscend Corp & Columbia Care Inc Made the Headlines with Positive News. Key Developments to Note in the Proceedings of the Federal Legalization of Marijuana
With State cannabis legalizationLatest CANN GROUP LIMITED(CAN) News
Cann Group First Half 2023 Earnings: AU$0.053 loss per share (vs AU$0.028 loss in 1H 2022)
Cann Group (ASX:CAN) adds AU$14m to market cap in the past 7 days, though investors from three years ago are still down 79%
The past three years for Cann Group (ASX:CAN) investors has not been profitable
Shareholders in Cann Group (ASX:CAN) are in the red if they invested three years ago
Cannabis Sector Weekly Roundup
Get access to daily BUY & SELL signals, advanced AI analysis, watchlists and email alerts.
14 Day Free Trial • Cancel Anytime • Founders Price $15/month
Start My Free Trial